Evaluation and Regulation of Medical Artificial Intelligence Applications in China.

Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published Date:

Abstract

Amid the global wave of digital economy, China's medical artificial intelligence applications are rapidly advancing through technological innovation and policy support, while facing multifaceted evaluation and regulatory challenges. The dynamic algorithm evolution undermines the consistency of assessment criteria, multimodal systems lack unified evaluation metrics, and conflicts persist between data sharing and privacy protection. To address these issues, the China National Health Development Research Center has established a value assessment framework for artificial intelligence medical technologies, formulated the country's first technical guideline for clinical evaluation, and validated their practicality through scenario-based pilot studies. Furthermore, this paper proposes introducing a "regulatory sandbox" model to test technical compliance in controlled environments, thereby balancing innovation incentives with risk governance.

Authors

  • Mao You
    China National Health Development Research Center, Beijing 100044, China.
  • Yue Xiao
    School of Mechanical Engineering, Nanchang Institute of Technology, Nanchang, Jiangxi 330099, China.
  • Han Yao
    School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Xue-Qing Tian
    China National Health Development Research Center, Beijing 100044, China.
  • Li-Wei Shi
    China National Health Development Research Center, Beijing 100044, China.
  • Ying-Peng Qiu
    China National Health Development Research Center, Beijing 100044, China. qyp@nhei.cn.